Morris Laster

Morris C.
Laster is the founder of Xerem Medical Ltd. founded in 2015.
Dr. Laster was the founder of BioLineRx Ltd. founded in 2003 and served as Director from 2003 to 2009.
Dr. Laster was the founder of C.G.M.3 Ltd. founded in 2007 and served as Director from 2007 to 2011.
Dr. Laster was the founder of Purple Biotech Ltd. founded in 2011 and served as Chief Executive Officer from 2011 to 2014.
Dr. Laster is also the founder of Neose Technologies, Inc.,XTL Biopharmaceuticals Ltd...
Dr. Laster is Chief Executive Officer at Clil Medical Ltd. Dr. Laster is Director at Dynamix Pharmaceuticals Ltd. Dr. Laster is Director at HIL Applied Medical Ltd. Dr. Laster is Director at Nanolabz, Inc. Dr. Laster is Director at BrainQ Technologies Ltd. Dr. Laster is Director at DreaMed Diabetes Ltd. Dr. Laster is Medical Venture Partner at Ourcrowd Medtech Fund since 2013.
Dr. Laster was Chairman & Chief Executive Officer at Keryx Biopharmaceuticals, Inc. from 1997 to 2002.
Dr. Laster was Co-Chairman & Chief Executive Officer at Scopus Biopharma, Inc. from 2017 to 2021.
Dr. Laster was Independent Director at Scinai Immunotherapeutics Ltd. from 2017 to 2025.
Dr. Laster was Director at OncoHost Ltd. Dr. Laster was Managing Partner at OurCrowd Management Ltd. from 2013 to 2025.
Dr. Laster was Vice President-Medical Venture Capital at Paramount Capital Investments LLC in 1996.
Dr. Laster earned an undergraduate degree from State University of New York at Albany in 1986.
Dr. Laster earned a doctorate from State University of New York at Downstate Medical Center in 1990.